Overview

Drug Use-Results Survey of Betanis Tablets in Japan

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This study is to determine the following information. 1. The occurrence of adverse drug reactions in clinical settings. 2. Factors potentially impacting safety, effectiveness, and other aspects.
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Mirabegron